Benitec Biopharma (BNTC) vs Emergent BioSolutions (EBS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Emergent BioSolutions is the larger company by market cap ($362.5 million vs $313.6 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | BNTC | EBS |
|---|---|---|
| Share price | $8.99 | $7.07 |
| Market cap | $313.60M | $362.50M |
| 1-day change | -0.11% | +1.73% |
| YTD return | — | -42.80% |
| 1-year return | — | -28.73% |
| 5-year return | — | -86.05% |
| Forward P/E | — | 6.76 |
| EPS (TTM) | $-0.98 | $-3.40 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.76 | $14.06 |
| 52-week low | $8.52 | $4.36 |
| Distance from 52-week high | -46.36% | -49.72% |
| Average volume | 150.34K | 1.16M |
| Shares outstanding | 34.88M | 51.27M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
BNTC vs EBS FAQ
Which is bigger, Benitec Biopharma or Emergent BioSolutions?
Emergent BioSolutions (EBS) is larger, with a market capitalization of $362.50M compared with $313.60M for Benitec Biopharma (BNTC).
Are Benitec Biopharma and Emergent BioSolutions in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.